Vironexis Biotherapeutics | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

726 results for “Vironexis Biotherapeutics”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

82 participants · First posted Oct 20, 2014

Enrolling By Invitation

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

400 participants · First posted Mar 20, 2025

FST-201 in the Treatment of Acute Otitis Externa

70 participants · First posted Aug 19, 2009

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

30 participants · First posted Jul 17, 2009

FST-201 In The Treatment of Acute Otitis Externa

5 participants · First posted Jul 24, 2009

Vaginal LIve Biotherapeutic RANdomized Trial

24 participants · First posted Nov 18, 2023

Impact of Clinician-administered Vaginal Live Biotherapeutic Product

26 participants · First posted Dec 26, 2025

Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer

9 participants · First posted Jul 12, 2023

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

63 participants · First posted Aug 20, 2018

A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19

First posted Apr 27, 2020

Page 1 of 2